Rivaroxaban, a Direct Inhibitor of Factor Xa, Attenuates Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mice Through the Inhibition of Protease-Activated Receptor 2 Signaling.

被引：0
|
作者：
Pham, Phuong T. [1 ]
Fukuda, Daiju [2 ]
Yagi, Shusuke [1 ]
Kusunose, Kenya [1 ]
Yamada, Hirotsugu [1 ]
Soeki, Takeshi [1 ]
Shimabukuro, Michio [2 ]
Sata, Masataka [1 ]
机构：
[1] Tokushima Univ, Grad Sch, Biomed Sci, Cardiovasc Med, Tokushima, Japan
[2] Tokushima Univ, Grad Sch, Biomed Sci, Cardiodiabet Med, Tokushima, Japan
来源：
CIRCULATION | 2018年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10787
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice
    Tao-Cheng Wu
    Jenq-Shyong Chan
    Chiu-Yang Lee
    Hsin-Bang Leu
    Po-Hsun Huang
    Jia-Shiong Chen
    Shing-Jong Lin
    Jaw-Wen Chen
    Cardiovascular Diabetology, 14
  • [2] Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice
    Wu, Tao-Cheng
    Chan, Jenq-Shyong
    Lee, Chiu-Yang
    Leu, Hsin-Bang
    Huang, Po-Hsun
    Chen, Jia-Shiong
    Lin, Shing-Jong
    Chen, Jaw-Wen
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [3] Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor Pathway
    Ichikawa, Hiroaki
    Shimada, Michiko
    Narita, Masato
    Narita, Ikuyo
    Kimura, Yoshihiro
    Tanaka, Makoto
    Osanai, Tomohiro
    Okumura, Ken
    Tomita, Hirofumi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (08):
  • [4] Antagonism of protease-activated receptors salvages vascular endothelial dysfunction in KK-Ay diabetic mice: a novel mechanism of rivaroxaban, an oral factor Xa inhibitor
    Shimabukuro, M.
    Matsumoto, S.
    Fukuda, D.
    Hara, T.
    Soeki, T.
    Sata, M.
    EUROPEAN HEART JOURNAL, 2014, 35 : 447 - 447
  • [5] Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Angiotensin II-induced Renal Damage Through Inhibition of Protease-activated Receptor Pathway-mediated Inflammatory Response
    Ichikawa, Hiroaki
    Shimada, Michiko
    Narita, Masato
    Kimura, Yoshihiro
    Senoo, Maiko
    Narita, Noritomo
    Yonekura, Manabu
    Tanaka, Makoto
    Osanai, Tomohiro
    Okumura, Ken
    Tomita, Hirofumi
    CIRCULATION, 2017, 136
  • [6] Rivaroxaban, a direct factor Xa inhibitor, ameliorates angiotensin II-induced renal damage through inhibition of protease-activated receptor pathway-mediated inflammatory response
    Ichikawa, H.
    Narita, M.
    Nishizaki, K.
    Kimura, Y.
    Seno, M.
    Narita, N.
    Yonekura, M.
    Tanaka, M.
    Shimada, M.
    Osanai, T.
    Okumura, K.
    Tomita, H.
    EUROPEAN HEART JOURNAL, 2017, 38 : 940 - 940
  • [7] Protease-activated receptor-1 deficiency protects against streptozotocin-induced diabetic nephropathy in mice
    Maaike Waasdorp
    JanWillem Duitman
    Sandrine Florquin
    C. Arnold Spek
    Scientific Reports, 6
  • [8] Protease-activated receptor-1 deficiency protects against streptozotocin-induced diabetic nephropathy in mice
    Waasdorp, Maaike
    Duitman, JanWillem
    Florquin, Sandrine
    Spek, C. Arnold
    SCIENTIFIC REPORTS, 2016, 6
  • [9] Antagonism of protease-activated receptor 2 (PAR-2) rescues vascular endothelial dysfunction in diabetic mice
    Hashimoto, R.
    Shimabukuro, M.
    Salim, H. M.
    Hara, T.
    Fukuda, D.
    Yagi, S.
    Soeki, T.
    Sata, M.
    EUROPEAN HEART JOURNAL, 2015, 36 : 91 - 91
  • [10] Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice
    Narita, Masato
    Hanada, Kenji
    Kawamura, Yosuke
    Ichikawa, Hiroaki
    Sakai, Shuntaro
    Yokono, Yoshikazu
    Senoo, Maiko
    Narita, Noritomo
    Shimada, Michiko
    Osanai, Tomohiro
    Okumura, Ken
    Tomita, Hirofumi
    HYPERTENSION RESEARCH, 2021, 44 (10) : 1261 - 1273
12345